SEC Comment Letter 0000000000-24-008632 to Yubo International Biotech Ltd (YBGJ)
Yubo International Biotech Ltd
Date: July 29, 2024 · CIK: 0000895464 · Accession: 0000000000-24-008632
AI Filing Summary & Sentiment
File numbers found in text: 000-21320
Letter
July 29, 2024 Lina Liu Chief Financial Officer Yubo International Biotech Ltd Room 105, Building 5, 31 Xishiku Avenue Xicheng District, Beijing, China 100034 Re:Yubo International Biotech Ltd Form 10-K filed April 12, 2024 File No. 000-21320 Dear Lina Liu: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services
Show Raw Text
July 29, 2024
Lina Liu
Chief Financial Officer
Yubo International Biotech Ltd
Room 105, Building 5, 31 Xishiku Avenue
Xicheng District, Beijing, China 100034
Re:Yubo International Biotech Ltd
Form 10-K filed April 12, 2024
File No. 000-21320
Dear Lina Liu:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services